PDCD1 and melanoma: In another prospective cohort study (98) involving 15 patients with hepatic metastases from melanoma, it was shown that after a single cycle of cryoablation combined with a PD-1 blocker (pembrolizumab), there was a significant increase in NK cells in the patients’ peripheral blood and a decrease in Tregs.